Given the established role of cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor alpha in the pathophysiology of heart failure, it is plausible that the symptomatic relief associated with MSCs may be, at least partly, secondary to their immunomodulatory capacity [60]. Here, IL6 is linked to heart failure.